Position in MDGL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,477,227
-$806,334 QoQ
Shares Held
12,063
-13.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#110
of 411 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Dec 31, 2024CallValue
$61,714
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. MDGL ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in MDGL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,477,227 | 12,063 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,283,561 | 13,914 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $683,084 | 1,173 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $516,909 | 1,127 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $410,682 | 1,357 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $471,340 | 1,423 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $61,714 | 200 | Call | Sole | 2025-02-07 | |
| 2024-12-31 | $455,757 | 1,477 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $355,680 | 1,676 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $499,805 | 1,784 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $80,112 | 300 | Call | Sole | 2024-05-06 | |
| 2024-03-31 | $371,185 | 1,390 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $208,936 | 903 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $138,828 | 600 | Put | Sole | 2024-02-12 | |
| 2022-12-31 | $208,980 | 720 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||